Immune Checkpoint Inhibitors Market to Reach $189.3 Billion, Globally by 2032 at 16.8% CAGR: Allied Market Research
Increase in incidences of cancer across the globe, rise in geriatric population and supportive reimbursement policies for immune checkpoint inhibitors is driving the market growth.Wilmington, New Castle, Delaware, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Immune Checkpoint Inhibitors Market By Type (CTLA-4 Inhibitor, PD-1 Inhibitor, PD-L1 Inhibitor), By Application (Lung Cancer, Bladder Cancer, Melanoma, Colorectal Cancer, Hodgkin Lymphoma, Others): Gl